Hsc70通过向PD-L1以进行溶酶体降解来促进抗瘤免疫力
Xiaoyan Xu1, Tingxue Xie1,2, Mengxin Zhou1,2
1Research Center of Clinical Pharmacy of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
Nature communications
|May 18, 2024
概括
热冲击相关蛋白70 (Hsc70) 促进编程细胞死亡连接体1 (PD-L1) 降解,减少其细胞表面循环. 抑制Hsc70或使用AUY-922可以增强抗瘤免疫力和免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 针对PD-1/PD-L1通路的免疫检查点抑制剂是关键的癌症疗法.
- 对这些疗法的耐药性可能来自PD-L1内部化和回收.
- lysosome介导的PD-L1降解对于防止其膜回收来说至关重要.
研究的目的:
- 阐明Hsc70在PD-L1降解和回收中的作用.
- 确定针对Hsc70进行增强癌症免疫治疗的治疗策略.
主要方法:
- 研究了Hsc70对通过内体-溶解体通路的PD-L1降解的影响.
- 研究了Hsc70,PD-L1和CMTM6.1之间的相互作用.
- 使用一种Hsp90α/β抑制剂 (AUY-922) 来调节Hsc70表达和PD-L1水平.
- 评估了Hsc70调制和AUY-922对小鼠瘤生长和抗瘤免疫力的影响.
主要成果:
- Hsc70通过内体-溶解体通路促进PD-L1降解,减少PD-L1的循环.
- Hsc70与PD-L1的结合抑制了CMTM6-PD-L1的相互作用,促进了降解.
- AUY-922治疗增加了Hsc70的表达,导致PD-L1 lysosomal降解的增强.
- Hsc70过度表达或AUY-922治疗减少PD-L1表达,抑制瘤生长,并增强抗瘤免疫力.
- AUY-922与抗PD-L1和抗CTLA4疗法协同作用,以提高抗瘤疗效.
结论:
- Hsc70是PD-L1 lysosomal降解的关键调节者.
- 针对Hsc70介导的PD-L1降解提供了一种新的策略,以克服癌症免疫治疗中的抗性.
- AUY-922 是一种潜在的治疗剂,可以增强现有免疫疗法的有效性.
更多相关视频
相关概念视频
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


